Optimisation of herpes simplex virus-based vectors for delivery to human peripheral blood mononuclear cells

Journal of Immunological Methods

Volumn 270, Issue 2, 2002, Pages 235-246

  Papageorgiou, Konstantina ^a   Isenberg, David A ^b   Latchman, David S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Gene delivery; Herpes simplex virus; Peripheral blood mononuclear cells; Virus vector

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; WESTERN BLOTTING;

ANIMALS; CELL LINE; CELLS, CULTURED; CRICETINAE; GENE DELETION; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HERPES SIMPLEX VIRUS PROTEIN VMW65; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; LEUKOCYTES, MONONUCLEAR; LUMINESCENT PROTEINS; VIRAL PROTEINS;

SIMPLEXVIRUS;

EID: 0037114285     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00299-5     Document Type: Article

References (30)

1. Ace C.I., McKee T.A., Ryan M., Cameron J.M., Preston C.M. Construction and characterization of a herpes simplex virus type I mutant unable to transduce immediate-early gene expression. Journal of Virology. 63:1989;2260.
2. Albers I., Kirchner H., Domke-Opitz I. Resistance of human blood monocytes to infection with herpes simplex virus. Virology. 169:1989;466.
3. Brown S.M., Ritchie D.A., Subak-Sharpe J.H. Genetic studies with herpes simplex virus type-1. Journal of General Virology. 18:1973;329.
4. Chinnasamy D., Chinnasamy N., Enriquez M.J., Otsu M., Morgan R.A., Candotti F. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood. 96:2000;1309.
5. Coffin R.S., Howard M.K., Cumming D.V.E., Dollery C.M., McEwan J., Yellon D.M., Marber M.S., Maclean A.R., Brown S.M., Latchman D.S. Gene delivery to cardiac cells in vitro and in vivo using herpes simplex virus vectors. Gene Therapy. 3:1996;560.
6. Coffin R.S., Maclean A.R., Latchman D.S., Brown S.M. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Therapy. 3:1996;886.
7. Coffin R.S., Thomas S.K., Thomas N.S.B., Lilley C.E., Pizzey A.R., Griffiths C.H., Gibb B.J., Wagstaff M.J.D., Inges S.J., Binks M.H., Chain B.M., Thrasher A.J., Rutault K., Latchman D.S. Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry. Gene Therapy. 5:1998;718.
8. Dardalhon V., Jaleco S., Rebouissou C., Ferrand C., Skander N., Swainson L., Tiberghien P., Spits H., Noraz N., Taylor N. Highly efficient gene transfer in naive human T cells with a murine leukemia virus-based vector. Blood. 96:2000;885.
9. Dhillon V.B., McCallum S., Norton P.M., Twomey B.M., Erkeller-Yuksel F., Lydyard P., Isenberg D.A., Latchman D.S. Differential heat shock protein over-expression and its clinical relevance in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 52:1993;436.
10. Dunbar C.E. In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectors. Blood. 94:1999;2263.
11. Heim D.A., Dunbar C.E. Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency. Immunological Reviews. 178:2000;29.
12. Hiller C., Wittmann S., Slavin S., Fickenscher H. Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector. Gene Therapy. 7:2000;664.
13. Howard M.K., Kershaw T., Gibb B., Storey W., Maclean A.R., Zeng B.-W., Jenner P., Brown S.M., Woolf C.J., Anderson P.N., Coffin R.S., Latchman D.S. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Therapy. 5:1998;1137.
14. Jensen M.C., Clarke P., Tan G., Wright C., Chung-Chang W., Clark T.N., Zhang F., Slovak M.L., Wu A.M., Forman S.J., Raubitschek A. Human T lymphocyte genetic modification with naked DNA. Molecular Therapy. 1:2000;49.
15. Kemp L.M., Estridge J.K., Brennan A., Katz D., Latchman D.S. Mononuclear phagocytes and HSV-1 infection: increased permissivity in differentiated U937 cells is mediated by post-transcriptional regulation of viral immediate early gene expression. Journal of Leukocyte Biology. 47:1990;483.
16. Latchman D.S. Gene therapy using herpes simplex virus based vectors. Histology and Histopathology. 15:2000;1253.
17. Latchman D.S. Gene delivery and gene therapy with herpes simplex-virus based vectors. Gene. 264:2001;1.
18. Li Y., Starr S.E., Lisziewicz J., Ho W.Z. Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer. Gene Therapy. 7:2000;321.
19. Lilley C.E., Groutsi F., Han Z.Q., Palmer J.A., Anderson P.N., Latchman D.S., Coffin R.S. Multiply disabled herpes simplex virus vectors optimised for the widespread and long term delivery of genes to the brain and spinal cord. Journal of Virology. 75:2001;4343.
20. Nakajima T., Kinoshita S., Sasagawa T., Sasaki K., Naruto M., Kishimoto T., Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen activated protein kinase cascade is essential for transcription factor NF-IL6. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;2207.
21. Palmer J., Branston R., Lilley C.E., Robinson M., Groutsi F., Smith J., Latchman D.S., Coffin R.S. Development and optimisation of herpes simplex virus vectors for multiple long term gene delivery to the peripheral nervous system. Journal of Virology. 74:2000;5604.
22. Pan D., Shankar R., Stroncek D.F., Whitley C.B. Combined ultrafiltration-transduction in a hollow-fibre bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II. Human Gene Therapy. 10:1999;2799.
23. Stephanou A.S., Amin V., Isenberg D.A., Akira S., Kishimoto T., Latchman D.S. Interleukin-6 activates heat shock protein 90β gene expression. Biochemical Journal. 321:1997;103.
24. Stephanou A.S., Isenberg D.A., Akira S., Kishimoto T., Latchman D.S. The NF-IL6 and STAT-3 signalling pathways cooperate to mediate the activation of the HSP90β gene by IL-6 but have opposite effects on its inducibility by heat shock. Biochemical Journal. 330:1998;189.
25. Stroncek D.F., Hubel A., Shankar R.A., Burger S.R., Pan D., McCullough J., Whitley C.B. Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome. Transfusion. 39:1999;343.
26. Tenney D.J., Morahan P.S. Effects of differentiation of human macrophage-like U937 cells on intrinsic resistance to herpes simplex virus type 1. Journal of Immunology. 139:1987;3076.
27. Thomas S.K., Gough G., Latchman D.S., Coffin R.S. The herpes simplex virus latency associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression and is likely to function during the reactivation from virus latency. Journal of Virology. 73:1999;6618.
28. Thomas S.K., Lilley C.E., Latchman D.S., Coffin R.S. Equine herpes virus 1 gene 12 can substitute for Vmw65 in the growth of herpes simplex virus 1 (HSV1) allowing the generation of optimised cell lines for the propagation of vectors with multiple immediate-early gene defects. Journal of Virology. 73:1999;7399.
29. Wegenka U.M., Buschmann J., Lutticken C., Heinrich P.C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Molecular and Cellular Biology. 13:1993;276.
30. Williams D.A., Smith F.O. Progress in the use of gene transfer methods to treat genetic blood diseases. Human Gene Therapy. 11:2000;2059.